{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:10:59Z","timestamp":1794978659406,"version":"4.9.1"},"reference-count":43,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Hemostatic impairment may exacerbate postpartum hemorrhage (PPH). Previously, we described a distinct coagulopathy, associated with multiple causes of PPH including placental abruption and amniotic fluid embolus, termed acute obstetric coagulopathy (AOC). AOC is characterized by very high plasmin\/antiplasmin complexes and rapid depletion of functional fibrinogen and factor V (FV). To determine mechanisms underlying AOC, we investigated the plasma from 12 women with AOC (defined by raised plasmin\/antiplasmin) and 21 with severe PPH (blood loss &amp;gt;2000 mL or placental abruption) without AOC. Plasma from patients with AOC had a fourfold increased ability to generate plasmin compared with those with severe PPH without AOC (P &amp;lt; .0002). AOC was associated with fibrinogen cleavage in the circulation, demonstrated by fragment D and other breakdown products (P &amp;lt; .0001). D-dimer was increased 36-fold in AOC compared with severe PPH without AOC, thrombin\/antithrombin complexes were not raised. FV was reduced on western blot in AOC but not severe PPH without AOC (P &amp;lt; .001) suggesting FV cleavage. Confocal microscopy revealed similar clot structure between AOC and non-AOC samples, but both groups differed from nonbleeding pregnant controls. These data suggest that in AOC an excess of plasmin cleaves fibrinogen and FV in the circulation causing a specific, pathognomonic depletion of coagulation factors. Fibrin(ogen) breakdown products have cofactor function for tissue plasminogen activator, and these data are consistent with these breakdown products, enhancing plasmin generation and potentially driving aberrant plasmin generation in AOC. These results have implications for the clinical management of coagulopathy during PPH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015514","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T15:02:31Z","timestamp":1738854151000},"page":"2751-2762","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":18,"title":["Acute obstetric coagulopathy is associated with excess plasmin generation and proteolysis of fibrinogen and factor V"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6410-1324","authenticated-orcid":false,"given":"Peter W.","family":"Collins","sequence":"first","affiliation":[{"name":"1Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8127-6102","authenticated-orcid":false,"given":"Claire S.","family":"Whyte","sequence":"additional","affiliation":[{"name":"2Aberdeen Diabetes and Cardiovascular Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4625-3260","authenticated-orcid":false,"given":"Lucy","family":"de Lloyd","sequence":"additional","affiliation":[{"name":"3Department of Anaesthetics, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-5716","authenticated-orcid":false,"given":"Anuj","family":"Narwal","sequence":"additional","affiliation":[{"name":"2Aberdeen Diabetes and Cardiovascular Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0476-1360","authenticated-orcid":false,"given":"Sarah F.","family":"Bell","sequence":"additional","affiliation":[{"name":"3Department of Anaesthetics, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Gill","sequence":"additional","affiliation":[{"name":"3Department of Anaesthetics, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Collis","sequence":"additional","affiliation":[{"name":"3Department of Anaesthetics, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5301-464X","authenticated-orcid":false,"given":"Peter V.","family":"Jenkins","sequence":"additional","affiliation":[{"name":"1Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom"},{"name":"4Department of Haematology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7452-0813","authenticated-orcid":false,"given":"Nicola J.","family":"Mutch","sequence":"additional","affiliation":[{"name":"2Aberdeen Diabetes and Cardiovascular Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"6","key":"2025061008220106500_bib1","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Global Health"},{"key":"2025061008220106500_bib2","doi-asserted-by":"crossref","first-page":"103547","DOI":"10.1016\/j.ijoa.2022.103547","article-title":"Comparison of haematological indices and transfusion management in severe and massive postpartum haemorrhage: analysis of a two-year national prospective observational study","volume":"50","author":"Bell","year":"2022","journal-title":"Int J Obstet Anesth"},{"issue":"8","key":"2025061008220106500_bib3","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.jtha.2023.03.029","article-title":"Managing the coagulopathy of postpartum hemorrhage: an evolving role for viscoelastic hemostatic assays","volume":"21","author":"Bell","year":"2023","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"2025061008220106500_bib4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jtha.2022.11.036","article-title":"Acute obstetric coagulopathy during postpartum hemorrhage is caused by hyperfibrinolysis and dysfibrinogenemia: an observational cohort study","volume":"21","author":"de Lloyd","year":"2023","journal-title":"J Thromb Haemostasis"},{"issue":"2","key":"2025061008220106500_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage","volume":"5","author":"Charbit","year":"2007","journal-title":"J Thromb Haemostasis"},{"issue":"11","key":"2025061008220106500_bib6","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood-2014-04-567891","article-title":"Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study","volume":"124","author":"Collins","year":"2014","journal-title":"Blood"},{"issue":"11","key":"2025061008220106500_bib7","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s00134-011-2315-0","article-title":"Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study","volume":"37","author":"Gayat","year":"2011","journal-title":"Intensive Care Med"},{"issue":"7","key":"2025061008220106500_bib8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/aogs.14828","article-title":"Management and outcomes of women with low fibrinogen concentration during pregnancy or immediately postpartum: a UK national population-based cohort study","volume":"103","author":"Diguisto","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"2025061008220106500_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41598-023-50911-w","article-title":"Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption","volume":"14","author":"Ide","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"2025061008220106500_bib10","first-page":"21","article-title":"DIC in pregnancy \u2013 pathophysiology, clinical characteristics, diagnostic scores, and treatments","volume":"13","author":"Erez","year":"2022","journal-title":"Hematol Res Rev"},{"issue":"7","key":"2025061008220106500_bib11","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/jth.14134","article-title":"A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH","volume":"16","author":"Suzuki","year":"2018","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"2025061008220106500_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jth.13174","article-title":"Management of coagulopathy associated with postpartum haemorrhage: guidance from the SSC of ISTH","volume":"14","author":"Collins","year":"2016","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"suppl 1","key":"2025061008220106500_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.14116","article-title":"FIGO recommendations on the management of postpartum hemorrhage 2022","volume":"157","author":"Escobar","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"2025061008220106500_bib14","first-page":"e106","article-title":"Prevention and management of postpartum haemorrhage","volume":"124","author":"Mavrides","year":"2016","journal-title":"Br J Obstet Gynaecol: An International Journal of Obstetrics and Gynaecology"},{"issue":"5","key":"2025061008220106500_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA, J Am Med Assoc"},{"issue":"2","key":"2025061008220106500_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bjh.12605","article-title":"How we manage the haematological aspects of major obstetric haemorrhage","volume":"164","author":"Allard","year":"2014","journal-title":"Br J Haematol"},{"issue":"2","key":"2025061008220106500_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/ACO.0000000000000295","article-title":"Causes of trauma-induced coagulopathy","volume":"29","author":"Davenport","year":"2016","journal-title":"Curr Opin Anaesthesiol"},{"issue":"4","key":"2025061008220106500_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/bja\/aeu086","article-title":"Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate","volume":"113","author":"Collins","year":"2014","journal-title":"Br J Anaesth"},{"issue":"33","key":"2025061008220106500_bib19","doi-asserted-by":"crossref","first-page":"15591","DOI":"10.1016\/S0021-9258(18)66755-9","article-title":"Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor","volume":"261","author":"Kimura","year":"1986","journal-title":"J Biol Chem"},{"issue":"1","key":"2025061008220106500_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1749-6632.2001.tb03517.x","article-title":"The structure and function of the alpha C domains of fibrinogen","volume":"936","author":"Weisel","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"2025061008220106500_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-030-53606-0_5","volume-title":"Trauma Induced Coagulopathy","author":"Mutch","year":"2021"},{"issue":"6","key":"2025061008220106500_bib22","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/S0021-9258(19)81051-7","article-title":"Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin","volume":"257","author":"Hoylaerts","year":"1982","journal-title":"J Biol Chem"},{"issue":"9","key":"2025061008220106500_bib23","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.14523","article-title":"DIC in obstetrics: diagnostic score, highlights in management, and international registry-communication from the DIC and Women's Health SSCs of the International Society of Thrombosis and Haemostasis","volume":"17","author":"Rabinovich","year":"2019","journal-title":"J Thromb Haemostasis"},{"issue":"10","key":"2025061008220106500_bib24","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/jth.15806","article-title":"The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1","volume":"20","author":"Whyte","year":"2022","journal-title":"J Thromb Haemostasis"},{"issue":"12","key":"2025061008220106500_bib25","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.jtha.2023.09.007","article-title":"Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis","volume":"21","author":"Simpson","year":"2023","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"2025061008220106500_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12884-021-03853-y","article-title":"Reduction in massive postpartum haemorrhage and red blood cell transfusion during a national quality improvement project, Obstetric Bleeding Strategy for Wales, OBS Cymru: an observational study","volume":"21","author":"Bell","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4950","key":"2025061008220106500_bib27","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/2031184a0","article-title":"Inhibition of thrombin and of fibrin polymerization, two activities derived from plasmin-digested fibrinogen","volume":"203","author":"Latallo","year":"1964","journal-title":"Nature"},{"issue":"3","key":"2025061008220106500_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1042\/bj1970661","article-title":"Characterization of the inhibition of fibrin assembly by fibrinogen fragment D","volume":"197","author":"Williams","year":"1981","journal-title":"Biochem J"},{"issue":"3","key":"2025061008220106500_bib29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/bja\/aex181","article-title":"Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial","volume":"119","author":"Collins","year":"2017","journal-title":"Br J Anaesth"},{"issue":"12","key":"2025061008220106500_bib30","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1538-7836.2009.03633.x","article-title":"Pharmacokinetics and safety of fibrinogen concentrate","volume":"7","author":"Manco-Johnson","year":"2009","journal-title":"J Thromb Haemostasis"},{"issue":"13","key":"2025061008220106500_bib31","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1021\/bi0525730","article-title":"Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin","volume":"45","author":"Schaefer","year":"2006","journal-title":"Biochemistry"},{"issue":"8","key":"2025061008220106500_bib32","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1055\/a-1719-5584","article-title":"The story of the fibrin(ogen) \u03b1C-domains: evolution of our view on their structure and interactions","volume":"122","author":"Medved","year":"2022","journal-title":"Thromb Haemost"},{"issue":"23","key":"2025061008220106500_bib33","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1182\/blood-2011-02-333203","article-title":"The antifibrinolytic function of factor XIII is exclusively expressed through \u03b1\u2082-antiplasmin cross-linking","volume":"117","author":"Fraser","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2025061008220106500_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0049-3848(82)90055-X","article-title":"Activation of plasminogen by tissue activator is increased specifically in the presence of certain soluble fibrin(ogen) fragments","volume":"27","author":"Verheijen","year":"1982","journal-title":"Thromb Res"},{"issue":"3","key":"2025061008220106500_bib35","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1172\/JCI115069","article-title":"Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis","volume":"87","author":"Weitz","year":"1991","journal-title":"J Clin Investig"},{"issue":"1","key":"2025061008220106500_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-0039-1696944","article-title":"Clot structure and implications for bleeding and thrombosis","volume":"46","author":"Mihalko","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"2025061008220106500_bib37","doi-asserted-by":"crossref","first-page":"103573","DOI":"10.1016\/j.ijoa.2022.103573","article-title":"A description of the coagulopathy characteristics in amniotic fluid embolism: a case report","volume":"51","author":"Oliver","year":"2022","journal-title":"Int J Obstet Anesth"},{"issue":"4","key":"2025061008220106500_bib38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00404-020-05466-w","article-title":"Amniotic fluid embolism-associated coagulopathy: a single-center observational study","volume":"301","author":"Schr\u00f6der","year":"2020","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"2025061008220106500_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajogmf.2019.100083","article-title":"Amniotic fluid embolism syndrome: analysis of the United States International Registry","volume":"2","author":"Stafford","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"3","key":"2025061008220106500_bib40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/bja\/aex245","article-title":"Viscoelastometry guided fresh frozen plasma infusion for postpartum haemorrhage: OBS2, an observational study","volume":"119","author":"Collins","year":"2017","journal-title":"Br J Anaesth"},{"issue":"2","key":"2025061008220106500_bib41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/anae.12859","article-title":"Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage","volume":"70","author":"Mallaiah","year":"2015","journal-title":"Anaesthesia"},{"issue":"2","key":"2025061008220106500_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0301-2115(97)00101-2","article-title":"Generation of thrombin in blood plasma of non-pregnant and pregnant women studied through concentration of thrombin\u2013antithrombin III complexes","volume":"75","author":"Uszy\u0144ski","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"10084","key":"2025061008220106500_bib43","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial [published correction appears in Lancet. 2017;389(10084):2104]","volume":"389","author":"Shakur","year":"2017","journal-title":"Lancet"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/11\/2751\/2377247\/blooda_adv-2024-015514-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/11\/2751\/2377247\/blooda_adv-2024-015514-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T08:22:13Z","timestamp":1749543733000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/11\/2751\/535486\/Acute-obstetric-coagulopathy-is-associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,6,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015514","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,10]]},"published":{"date-parts":[[2025,5,30]]}}}